| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/05/1998 | US5747491 Morpholine derivatives and their use as antagonists of tachikinins |
| 05/05/1998 | US5747481 Analgesics and antiinflammaory agents |
| 05/05/1998 | US5747462 Pharmaceutically active compounds and their use |
| 05/05/1998 | US5747319 Human mRNA editing enzyme |
| 05/05/1998 | US5747303 Intermediates of peptide antagonists of neurotensin |
| 05/05/1998 | US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae |
| 05/05/1998 | US5747068 Flouxetine pharmaceutical formulations |
| 05/05/1998 | CA2152588C Anti-androgenic cyclo and bicyclo alkenes |
| 04/30/1998 | WO1998017779A1 NOVEL FabH |
| 04/30/1998 | WO1998017672A1 Substituted aminoalkane phosphonic acids |
| 04/30/1998 | WO1998017652A1 Oxadiazoles, processes for their preparation and their use as medicaments |
| 04/30/1998 | WO1998017651A1 1-phenyl-benzimidazole compounds and their use as baga-a receptor modulators |
| 04/30/1998 | WO1998017627A1 Substituted gamma aminobutyric acids as pharmaceutical agents |
| 04/30/1998 | WO1998017325A2 Covalent polar lipid conjugates for targeting |
| 04/30/1998 | WO1998017307A1 Method and composition for treating neuronal degeneration |
| 04/30/1998 | WO1998017292A1 Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium |
| 04/30/1998 | WO1998017289A1 Therapeutic use of hemoglobin to treat head injury |
| 04/30/1998 | WO1998017285A1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics |
| 04/30/1998 | WO1998017278A1 Neurotrophin antagonist compositions |
| 04/30/1998 | WO1998017230A2 New 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives |
| 04/30/1998 | WO1998004694A3 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | WO1998004249A3 Tramadol multiple unit formulations |
| 04/30/1998 | DE19644501A1 GABA¶A¶-Rezeptoruntereinheit epsilon-verwandtes Protein GABA¶A¶ receptor epsilon subunit-related protein |
| 04/30/1998 | CA2268517A1 Therapeutic use of hemoglobin to treat head injury |
| 04/30/1998 | CA2267114A1 1-phenyl-benzimidazole compounds and their use as gaba-a receptor modulators |
| 04/29/1998 | EP0838523A2 RsbW-1 derived from Staphylococcus |
| 04/29/1998 | EP0838220A1 Drug for ameliorating brain diseases |
| 04/29/1998 | EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque |
| 04/29/1998 | EP0837939A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 04/29/1998 | EP0837938A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 04/29/1998 | EP0837874A2 Neuroactive steroids of the androstane and pregnane series |
| 04/29/1998 | EP0837864A1 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
| 04/29/1998 | EP0837858A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 04/29/1998 | EP0837854A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 04/29/1998 | EP0837848A1 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 04/29/1998 | EP0536269B1 The use of inositoltrisphosphate for the preparing of medicaments |
| 04/29/1998 | CN1180357A 5H, 10H-imidazo £1, 2 -a| indeno £1, 2 -e| pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 04/29/1998 | CN1180352A Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 04/29/1998 | CN1180311A Use of 'alpha' 1L agonists in treatment of incontinence |
| 04/29/1998 | CN1179980A Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 04/29/1998 | CN1179959A Chinese patent drug |
| 04/28/1998 | US5744607 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 04/28/1998 | US5744500 Administering to treat brain ischemia or stroke |
| 04/28/1998 | US5744493 3-amidopyrazole derivatives and pharmaceutical compositions containing them |
| 04/28/1998 | US5744491 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 04/28/1998 | US5744489 Administering certain 1,2,5-thiadiazole and 1,2,5-oxadiazole compounds |
| 04/28/1998 | US5744483 Neuroprotective compounds |
| 04/28/1998 | US5744480 Antiinflammatory agents, nervous system disorders |
| 04/28/1998 | US5744471 Pyridazion quinoline compounds |
| 04/28/1998 | US5744466 Therapeutic heterocyclic compounds |
| 04/28/1998 | US5744458 Kappa agonist compounds and pharmaceutical formulations thereof |
| 04/28/1998 | US5744454 Anthracycline derivatives |
| 04/28/1998 | US5744165 Antiinflammatory agents, analgesics |
| 04/28/1998 | CA2056906C Use of phenylethanolaminotetralins for the preparation of anti-depressant and anti-stress pharmaceutical compositions |
| 04/28/1998 | CA2030108C Process for the preparation of genetic vectors for the expression of nerve growth factor in eukaryotic cells |
| 04/23/1998 | WO1998016834A1 Diagnosis of spongiform encephalopathy |
| 04/23/1998 | WO1998016530A1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONE |
| 04/23/1998 | WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016512A1 New derivates from piperidine-keto acid, their preparation and use |
| 04/23/1998 | WO1998016507A2 New heterocyclylmethyl-substituted pyrazol derivates and their use for treating cardiovascular diseases |
| 04/23/1998 | WO1998016506A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016505A1 SULFONAMIDE INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 04/23/1998 | WO1998016504A2 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 04/23/1998 | WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016502A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 04/23/1998 | WO1998016242A1 Method of enhancing the delivery of growth factors |
| 04/23/1998 | WO1998016238A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 04/23/1998 | WO1998016226A1 Use of lofexidine in the treatment of behavioral disorders |
| 04/23/1998 | WO1998016223A1 Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems |
| 04/23/1998 | WO1998016216A1 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 04/23/1998 | WO1998016208A1 Methods and apparatus for treatment of parkinson's disease |
| 04/23/1998 | WO1998016204A1 Process for the manufacture of a pulverous preparation |
| 04/23/1998 | WO1998001149A3 Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule |
| 04/23/1998 | DE19643037A1 Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel New oxadiazoles, processes for their preparation and their use as medicaments |
| 04/23/1998 | CA2269075A1 Method of enhancing the delivery of growth factors |
| 04/23/1998 | CA2268917A1 New derivates from piperidine-keto acid, their preparation and use |
| 04/23/1998 | CA2268904A1 Diagnosis of spongiform encephalopathy |
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268895A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268103A1 Sulfonamide substituted aspartic acid interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2268098A1 Aspartate ester inhibitors of interleukin-1.beta. converting enzyme |
| 04/23/1998 | CA2268086A1 Sulfonamide interleukin-1.beta. converting enzyme inhibitors |
| 04/22/1998 | EP0837129A1 Epimorphin antagonist and process for producing the same |
| 04/22/1998 | EP0837073A1 Human mad proteins and uses thereof |
| 04/22/1998 | EP0837061A1 Pharmaceutical acidic compounds |
| 04/22/1998 | EP0837055A1 Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them |
| 04/22/1998 | EP0836853A1 Use of bradykinin antagonists for the manufacture of a medicament for treating Alzheimer's disease |
| 04/22/1998 | EP0836849A2 Pharmaceutical formulations containing gamma amino butyric acid, an anti-oxidant, folic acid, nicotinamide and a lithium salt |
| 04/22/1998 | EP0836621A1 Novel human g-protein coupled receptor |
| 04/22/1998 | EP0836613A1 Water-soluble adenosine kinase inhibitors |
| 04/22/1998 | EP0836606A1 Condensed thiazole derivatives, having 5-ht receptor affinity |
| 04/22/1998 | EP0836604A1 Novel substituted azabicyclic compounds |
| 04/22/1998 | EP0836599A1 1,6-disubstituted isochromans for treatment of migraine headaches |
| 04/22/1998 | EP0836591A1 Semicarbazones having cns activity and pharmaceutical preparations containing same |
| 04/22/1998 | EP0836511A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 04/22/1998 | EP0836476A1 A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders |
| 04/22/1998 | EP0697871A4 Treatment process with biologically active tropane derivatives |
| 04/22/1998 | EP0618906B1 Substituted imidazole derivatives and their preparation and use |
| 04/22/1998 | EP0536275B1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |